o | Preliminary Proxy Statement | |
o | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
þ | Definitive Proxy Statement | |
o | Definitive Additional Materials | |
o | Soliciting Material Pursuant to §240.14a-12 |
þ | No fee required. | |
o | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
(1) | Title of each class of securities to which transaction applies: | ||
(2) | Aggregate number of securities to which transaction applies: | ||
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | ||
(4) | Proposed maximum aggregate value of transaction: | ||
(5) | Total fee paid: | ||
o | Fee paid previously with preliminary materials. | |
o | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
(1) | Amount Previously Paid: | ||
(2) | Form, Schedule or Registration Statement No.: | ||
(3) | Filing Party: | ||
(4) | Date Filed: | ||
Houston, Texas 77219-0548 | April 1, 2010 |
1. | To elect three nominees to the Board of Directors (the Board). | |
2. | To approve the appointment of PricewaterhouseCoopers LLP as SCIs independent registered public accounting firm for the 2010 fiscal year. | |
3. | To transact such other business that may properly come before the meeting. |
1 | ||||
4 | ||||
19 | ||||
29 | ||||
46 | ||||
46 | ||||
47 | ||||
49 | ||||
50 | ||||
51 |
| Election of three nominees to the Board of Directors. | |
| Approval of PricewaterhouseCoopers LLP as SCIs independent registered public accounting firm for the 2010 fiscal year. |
| Vote through the internet at www.proxyvote.com using the instructions on the proxy or voting instruction card. | |
| Vote by telephone using the toll-free number shown on the proxy or voting instruction card. | |
| Complete, sign and return a written proxy card in the pre-stamped envelope provided. | |
| Attend and vote at the meeting. |
1
| FOR each of the three nominees to the Board of Directors. Biographical information for each nominee is outlined in this Proxy Statement under Election of Directors. | |
| FOR approval of PricewaterhouseCoopers LLP as SCIs independent registered public accounting firm for the 2010 fiscal year. |
2
| Bylaws of SCI | |
| Charters of the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee | |
| Corporate Governance Guidelines | |
| Principles of Conduct and Ethics for the Board of Directors | |
| Code of Conduct and Ethics for Officers and Employees |
3
Alan R. Buckwalter | ||||||
Age: 63 | Director Since: 2003 | Term Expires: 2013 | ||||
Mr. Buckwalter retired in 2003 as Chairman of J.P. Morgan Chase Bank, South Region after a career of over 30 years in banking that involved management of corporate, commercial, capital markets, international, private banking and retail departments. He served as head of the Banking Division and Leveraged Finance Unit within the Banking and Corporate Finance Group of Chemical Bank and Chairman and CEO of Chase Bank of Texas. Mr. Buckwalter has attended executive management programs at Harvard Business School and the Stanford Executive Program at Stanford University. He is a Board member of the National Association of Corporate Directors (Houston chapter). He is also an avid community volunteer, serving on the Boards of Texas Medical Center and the American Red Cross (Houston chapter). The Board of Directors believes that Mr. Buckwalter should serve as a Director because of his executive, banking, financial and business experience as described above. | ||||||
SCI Common Shares Beneficially
Owned(1):
87,587 Other Directorships in Last Five Years: Plains Exploration and Production Company |
||||||
Victor L. Lund | ||||||
Age: 62 | Director Since: 2000 | Term Expires: 2013 | ||||
Since December 2006, Mr. Lund has served as Chairman of the Board of DemandTec, Inc., a software company. From May 2002 to December 2004, Mr. Lund served as Chairman of the Board of Mariner Healthcare, Inc. From 1999 to 2002, he served as Vice Chairman of the Board of Albertsons, Inc. prior to which he had a 22-year career with American Stores Company in various positions, including Chairman of the Board and Chief Executive Officer, Chief Financial Officer and Corporate Controller. Prior to that time, Mr. Lund was a practicing audit CPA for five years, held a CPA license and received the highest score on the CPA exam in the State of Utah in the year that he was licensed. He also holds an MBA and a BA in Accounting. The Board of Directors believes that Mr. Lund should serve as a Director because of his accounting expertise as well as his executive, financial and business experience as described above. | ||||||
SCI Common Shares Beneficially
Owned(1):
177,886 Other Directorships in Last Five Years: Borders Group, Del Monte Foods Company, Delta Airlines, Inc., DemandTec, Inc., Mariner Healthcare, Inc., NCR Corporation and Teradata Corporation |
||||||
4
John W. Mecom, Jr. | ||||||
Age: 70 | Director Since: 1983 | Term Expires: 2013 | ||||
Mr. Mecom has been involved in the purchase, management and sale of business interests in a variety of industries. He has owned and managed over 500,000 acres of surface and mineral interests throughout the U.S. He has been involved in the purchase, renovation, management and sale of luxury hotels in the U.S., Peru and Mexico. He purchased the New Orleans Saints NFL team in 1967 and sold his interest in 1985. He is currently Chairman of the John W. Mecom Company and principal owner of John Gardiners Tennis Ranch. The Board of Directors believes that Mr. Mecom should serve as a Director because of his varied executive, investment and business experience as described above. | ||||||
SCI Common Shares Beneficially
Owned(1):
100,199 Other Directorships in Last Five Years: None |
||||||
5
R. L. Waltrip | ||||||
Age: 79 | Director Since: 1962 | Term Expires: 2012 | ||||
Mr. Waltrip is the founder and Chairman of the Board of SCI. He has provided invaluable leadership to the Company for over 40 years. A licensed funeral director, Mr. Waltrip grew up in his familys funeral business and assumed management of the firm in the 1950s. He began buying additional funeral homes in the 1960s and achieved significant cost efficiencies through the cluster strategy of sharing pooled resources among numerous locations. At the end of 2009, the network he began had grown to include more than 1,600 funeral service locations and cemeteries. Mr. Waltrip took SCI public in 1969. Mr. Waltrip holds a bachelors degree in business administration from the University of Houston. The Board of Directors believes that Mr. Waltrip should serve as a Director because of his extensive knowledge and experience related to the death care industry and the Company as well as his executive and business experience as described above. | ||||||
SCI Common Shares Beneficially
Owned(1):
2,800,246(2) Other Directorships in Last Five Years: None |
||||||
Thomas L. Ryan | ||||||
Age: 44 | Director Since: 2004 | Term Expires: 2011 | ||||
Mr. Ryan was elected Chief Executive Officer of Service Corporation International in February 2005 and has served as President of SCI since July 2002. Mr. Ryan joined the Company in 1996 and served in a variety of financial management roles until November 2000, when he was asked to serve as Chief Executive Officer of European Operations. In July 2002, Mr. Ryan was appointed Chief Operating Officer of SCI, a position he held until February 2005. Before joining SCI, Mr. Ryan was a certified public accountant with Coopers & Lybrand LLP for eight years. He holds a bachelors degree in business administration from the University of Texas at Austin. Mr. Ryan serves on the Board of Directors of the American Diabetes Association. Mr. Ryan also serves on the Board of Trustees and the Executive Committee of the United Way of Greater Houston where he chaired the 2009-2010 Community Campaign. Mr. Ryan also serves on the Board of Directors of the Greater Houston Partnership. Mr. Ryan is a member and Chapter Secretary of the Young Presidents Organization. Mr. Ryan also serves on the University of Texas McCombs Business School Advisory Council. The Board of Directors believes that Mr. Ryan should serve as a Director because of his extensive knowledge and experience related to the death care industry and the Company as well as his executive, accounting and business experience as described above. | ||||||
SCI Common Shares Beneficially
Owned(1):
2,315,044(3) Other Directorships in Last Five Years: None |
||||||
6
Anthony L. Coelho | ||||||
Age: 67 | Director Since: 1991 | Term Expires: 2012 | ||||
Mr. Coelho was a member of the U.S. House of Representatives from 1978 to 1989. After leaving Congress, he joined Wertheim Schroder & Company, an investment banking firm in New York and became President and CEO of Wertheim Schroder Financial Services. From October 1995 to September 1997, he served as Chairman and CEO of an education and training technology company that he established and subsequently sold. He served as general chairman of the presidential campaign of former Vice President Al Gore from April 1999 until June 2000. Since 1997, Mr. Coelho has worked independently as a business and political consultant. Mr. Coelho also served as Chairman of the Presidents Committee on Employment of People with Disabilities from 1994 to 2001. He previously served as Chairman of the Board of the Epilepsy Foundation. The Board of Directors believes that Mr. Coelho should serve as a Director because of his political acumen and contacts as well as his executive, financial and business experience as described above. | ||||||
SCI Common Shares Beneficially
Owned(1):
100,727 Other Directorships in Last Five Years: CepTor Corporation, Cyberonics, Inc., Stem Cell Innovation, Inc., Universal Access Global Holdings, Inc. and Warren Resources, Inc. |
||||||
A.J. Foyt, Jr. | ||||||
Age: 75 | Director Since: 1974 | Term Expires: 2012 | ||||
Mr. Foyt achieved prominence as a racing driver who was the first four-time winner of the Indianapolis 500. His racing career spanned four decades and three continents North America, Europe and Australia. Since his retirement from racing in 1994, Mr. Foyt has engaged in a variety of commercial and entrepreneurial ventures. He is the President and owner of A. J. Foyt Enterprises, Inc. (assembly, exhibition and competition with high-speed engines and racing vehicles), and has owned and operated car dealerships that bear his name. He has also been involved in a number of commercial real estate investment and development projects, and has served as a director of a Texas bank. The Board of Directors believes that Mr. Foyt should serve as a Director because of his varied executive, investment and business experience as described above. | ||||||
SCI Common Shares Beneficially
Owned(1):
195,553 Other Directorships in Last Five Years: None |
||||||
7
Malcolm Gillis | ||||||
Age: 69 | Director Since: 2004 | Term Expires: 2011 | ||||
Malcolm Gillis, Ph.D., is a University Professor and former President of Rice University, a position he held from 1993 to June 2004. He is an internationally respected academician and widely published author in the field of economics with major experience in fiscal reform and environmental policy. Dr. Gillis has taught at Harvard and Duke Universities and has held named professorships at Duke and Rice Universities. He has served as a consultant to numerous U.S. agencies and foreign governments. Additionally, he has held memberships in many national and international committees, boards, and advisory councils. He holds Bachelors and Masters degrees from the University of Florida and a Doctorate from the University of Illinois. The Board of Directors believes that Dr. Gillis should serve as a Director because of his academic, economic, financial and business knowledge as well as his executive experience as described above. | ||||||
SCI Common Shares Beneficially
Owned(1):
54,697 Other Directorships in Last Five Years: AECOM Technology Corporation, Electronic Data Systems Corp., Halliburton Co. and Introgen Therapeutics, Inc. |
||||||
Clifton H. Morris, Jr. | ||||||
Age: 74 | Director Since: 1990 | Term Expires: 2011 | ||||
Mr. Morris has been Chairman of AmeriCredit Corp. (financing of automotive vehicles) since May 1988, previously having served as Chief Executive Officer and President of that company. Previously, he served as Chief Financial Officer of Cash America International, prior to which he owned his own public accounting firm. He is a certified public accountant with 46 years of certification, a Lifetime Member of the Texas Society of Certified Public Accountants and an Honorary Member of the American Institute of Certified Public Accountants. Mr. Morris was instrumental in the early formulation and initial public offerings of SCI, Cash America International and AmeriCredit Corp., all of which are now listed on the New York Stock Exchange. From 1966 to 1971, he served as Vice President of treasury and other financial positions at SCI, returning to serve on the Companys Board of Directors in 1990. Mr. Morris was named 2001 Business Executive of the Year by the Fort Worth Business Hall of Fame. He is also an avid community volunteer, having served on the Community Foundation of North Texas, Fort Worth Chamber of Commerce and Fort Worth Country Day School. The Board of Directors believes that Mr. Morris should serve as a Director because of his executive, financial, investment and business experience as well as his accounting expertise as described above. | ||||||
SCI Common Shares Beneficially
Owned(1):
148,227 Other Directorships in Last Five Years: AmeriCredit Corp. |
||||||
8
W. Blair Waltrip | ||||||
Age: 55 | Director Since: 1986 | Term Expires: 2011 | ||||
Mr. Waltrip held various positions with SCI from 1977 to 2000, including serving as Vice President of Corporate Development, Senior Vice President of Funeral Operations, Executive Vice President of SCIs real estate division, Chairman and CEO of Service Corporation International (Canada) Limited (a subsidiary taken public on The Toronto Stock Exchange) and Executive Vice President of SCI. Mr. Waltrips experience has provided him with knowledge of almost all aspects of the Company and its industry with specific expertise in North American funeral/cemetery operations and real estate management. Since leaving SCI in 2000, Mr. Waltrip has been an independent investor, primarily engaged in overseeing family and trust investments. Mr. Waltrip is the son of SCIs founder, R. L. Waltrip. The Board of Directors believes that Mr. Waltrip should serve as a Director because of his extensive knowledge and experience related to the death care industry and the Company as well as his executive and business experience as described above. | ||||||
SCI Common Shares Beneficially
Owned(1):
1,705,828 Other Directorships in Last Five Years: Sanders Morris Harris Group, Inc. |
||||||
Edward E. Williams | ||||||
Age: 64 | Director Since: 1991 | Term Expires: 2012 | ||||
Dr. Williams holds the Henry Gardiner Symonds Chair (an endowed professorship) at the Jesse H. Jones Graduate School of Management at Rice University, where he teaches classes on entrepreneurship, value creation, venture capital investing, business valuations, leveraged buyouts and the acquisition of existing concerns. Dr. Williams has been named by Business Week as the Number Two Entrepreneurship Professor in the United States. Dr. Williams holds a PhD with specialization in Finance, Accounting and Economics. He has taught finance, accounting, economics and entrepreneurship at the graduate level, has written numerous articles in finance, accounting, economics and entrepreneurship journals, has taught courses in financial statement analysis and continues to do academic research in his areas of specialty. He is the author or co-author of over 40 articles and nine books on business planning, entrepreneurship, investment analysis, accounting and finance. The Board of Directors believes that Dr. Williams should serve as a Director because of his academic, economic, accounting, financial, investment and business knowledge and experience as described above. | ||||||
SCI Common Shares Beneficially
Owned(1):
260,882 Other Directorships in Last Five Years: Equus Total Return, Inc. |
||||||
9
| the prospective nominees integrity, character and accountability; | |
| the prospective nominees ability to provide wise and thoughtful counsel on a broad range of issues; | |
| the prospective nominees financial literacy and ability to read and understand financial statements and other indices of financial performance; | |
| the prospective nominees ability to work effectively as part of a team with mature confidence; | |
| the prospective nominees ability to provide counsel to management in developing creative solutions and in identifying innovative opportunities; and | |
| the commitment of the prospective nominee to prepare for and attend meetings and to be accessible to management and other directors. |
10
11
Name
of Committee |
||
and Members | Functions of the Committee | |
Audit Committee
Victor L. Lund (Chair) Alan R. Buckwalter, III Malcolm Gillis Clifton H. Morris, Jr. Edward E. Williams Meetings In 2009 Four |
Assists the Board of Directors in
fulfilling its oversight responsibilities to ensure the
integrity of the Companys financial statements, the
Companys compliance with legal and regulatory
requirements, the qualifications, independence and performance
of the independent registered public accounting firm and the
performance and effectiveness of the Companys internal
audit function.
Reviews the annual audited financial statements with SCI management and the independent registered public accounting firm, including items noted under Managements Discussion and Analysis of Financial Condition and Results of Operations and any major issues regarding accounting principles and practices. This includes a review of analysis by management and discussion with the independent registered public accounting firm of any significant financial reporting issues and judgments made by management in the preparation of the financial statements, including the effect of alternative GAAP methods. |
|
Reviews SCIs quarterly financial
statements with management and the independent registered public
accounting firm prior to the release of quarterly earnings and
the filing of quarterly reports with the SEC, including the
results of the independent registered public accounting
firms reviews of the quarterly financial statements.
|
||
Reviews with management and the
independent registered public accounting firm the effect of any
major changes to SCIs accounting principles and practices,
as well as the impact of any regulatory and accounting
initiatives on SCIs financial statements.
|
||
Reviews the qualifications, independence
and performance of the independent registered public accounting
firm annually and recommends the appointment or re-appointment
of the independent registered public accounting firm. The Audit
Committee is directly responsible for the engagement,
compensation and replacement, if appropriate, of the independent
registered public accounting firm.
|
||
Meets at least quarterly with the
independent registered public accounting firm without SCI
management present. Reviews with the independent registered
public accounting firm any audit problems or difficulties and
managements responses to address these issues.
|
||
Meets with SCI management at least
quarterly to review any matters the Audit Committee believes
should be discussed.
|
||
Meets with SCI management to discuss
policies with respect to risk assessment and risk management and
to review SCIs major financial risks and steps management
has taken to monitor and control such exposures.
|
||
Reviews with the Companys legal
counsel any legal matters that could have a significant impact
on the Companys financial statements.
|
12
Name
of Committee |
||
and Members | Functions of the Committee | |
Audit
Committee (Contd)
|
Reviews and discusses summary reports
from SCIs Careline, a toll-free number available to
Company employees to make anonymous reports of any complaints or
issues regarding infringements of ethical or professional
practice by any SCI employee regarding financial matters;
discusses with SCI management actions taken in response to any
significant issues arising from these summaries.
|
|
In accordance with Section 404 of the
Sarbanes-Oxley Act of 2002, the Audit Committee also reviews
reports relative to the effectiveness of SCIs internal
control over financial reporting, including obtaining and
reviewing a report by the independent registered public
accounting firm regarding the effectiveness of SCIs
internal control over financial reporting. The Audit Committee
reviews any material issues raised by the most recent assessment
of the effectiveness of SCIs internal control over
financial reporting and any steps taken to deal with such issues.
|
||
13
Name
of Committee |
||
and Members | Functions of the Committee | |
Nominating and Corporate Governance Committee
Anthony L. Coelho (Chair) Alan R. Buckwalter, III Victor L. Lund John W. Mecom, Jr. Clifton H. Morris, Jr. Edward E. Williams Meetings In 2009 Four |
Oversees the composition of the Board of
Directors of SCI and the Board committees, including the process
for identifying and recruiting new candidates for the Board,
developing a re-nomination review process for current Board
members and considering nominees recommended by shareholders in
accordance with the bylaws.
Makes recommendations to the Board with respect to the nomination of candidates for Board membership and committee assignments, including the chairmanships of the Board committees. Provides leadership to the Board in the development of corporate governance principles and practices, including the development of Corporate Governance Guidelines and a Code of Business Conduct and Ethics. Oversees the Companys enterprise risk management function. In conjunction with the full Board, oversees CEO succession planning and reviews succession plans for other SCI executives, including the development of both short-term (emergency) and long-term CEO succession plans, and leadership development planning. Monitors progress against these plans and reports to the full Board on this issue at least annually. |
|
Develops and leads the annual Board
evaluation of the performance of the CEO and presents the
results of this evaluation to the full Board for discussion and
approval.
|
||
With outside assistance, when needed,
makes recommendations to the full Board with respect to
compensation for Board members.
|
||
Oversees the development of orientation
programs for new Board members in conjunction with SCIs
Chairman.
|
||
Oversees continuing education sessions
for SCI directors. This includes monitoring various director
education courses offered by universities and other
institutions, making recommendations to the Board as to which of
these might be most useful to attend, and developing other
education initiatives that may be practical and useful to Board
members, including development of a program for Board member
visits to SCI sites and facilities.
|
||
Oversees and implements the annual
process for assessment of the performance of SCIs Board
and of the Nominating and Corporate Governance Committee, and
coordinates the annual performance assessment of the Board
committees.
|
||
Oversees and implements the individual
peer review process for assessment of the performance of
individual members of the Board.
|
||
The Committee Chair presides at
executive sessions of non-management directors held during every
SCI Board meeting.
|
||
14
Name
of Committee |
||
and Members | Functions of the Committee | |
Investment Committee
Edward E. Williams (Chair) Anthony L. Coelho Malcolm Gillis John W. Mecom, Jr. W. Blair Waltrip Meetings In 2009 Four |
Assists the Board of Directors in
fulfilling its responsibility in the oversight management of
internal and external assets. Internal assets are short-term
investments for the Companys own account. External assets
are funds received by the Company and placed into Trust in
accordance with applicable state laws related to prearranged
sale of funerals, cemetery merchandise and services and
perpetual care funds (Trusts) which are deposited
with financial institutions (the Trustees).
Works in conjunction with the Investment Operating Committee of SCI, a committee comprised of senior SCI officers and other managers, which supports the Investment Committee by providing day-to-day oversight of the internal and external assets. The Investment Committees policies are implemented through the Investment Operating Committee of SCI. |
|
Provides guidance to the Trustees
regarding the management of the SCI U.S. Trust funds.
|
||
Determines that the Trusts assets
are prudently and effectively managed in accordance with the
investment policy.
|
||
Reviews, approves and recommends an
investment policy for the Trust funds including (1) asset
allocation, (2) individual consideration of each Trust type, (3)
acceptable risk levels,(4) total return or income objectives and
(5) investment guidelines relating to eligible investments,
diversification and concentration restrictions, and performance
objectives for specific managers or other investments.
|
||
Evaluates performance of the Trustees
and approves changes if needed.
|
||
Monitors adherence to investment policy
and evaluates performance based on achieving stated objectives.
|
||
Oversight responsibility for the
Companys cash investments on a short term basis.
|
||
Oversight responsibility for the
Companys prearranged funeral insurance.
|
||
Oversight responsibility for the
Companys retirement plans.
|
||
By law, the Trustees are ultimately
responsible for all investment decisions. However, the
Investment Committee in conjunction with the Investment
Operating Committee and a consultant, recommends investment
policies and guidelines and investment manager changes to the
Trustees.
|
||
15
Name
of Committee |
||
and Members | Functions of the Committee | |
Compensation Committee
Alan R. Buckwalter, III (Chair) Anthony L. Coelho Malcolm Gillis Victor L. Lund John W. Mecom, Jr. |
Oversees the compensation program for
SCIs executive officers with a view to ensuring that such
program attracts, motivates and retains executive personnel and
relates directly to objectives of the Company and shareholders
as well as the operating performance of the Company.
Sets compensation for the Chairman and the CEO of SCI, and reviews and approves compensation for all other SCI executive officers, including base salaries, short and long-term incentive compensation plans and awards and certain benefits. |
|
Meetings In 2009 Five |
Determines appropriate individual and
Company performance measures, including goals and objectives, to
be used in reviewing performance for the purposes of setting
compensation for the Chairman, CEO and other executive officers
as well as appropriate peer group companies to review for
comparative purposes with respect to compensation decisions.
|
|
Approves any executive employment
contracts for SCIs officers, including the Chairman and
the CEO.
|
||
Retains, as appropriate, compensation
consultants to assist the Committee in fulfilling its
responsibilities. The consultants report directly to the
Committee, which has sole authority to approve the terms of
their engagement, including their fees.
|
||
Determines SCI stock ownership
guidelines for officers, adjusts such guidelines if necessary
and reviews at least annually officer compliance with such
guidelines.
Assesses the risk of the Companys compensation programs. |
||
Executive Committee
Robert L. Waltrip (Chair) Alan R. Buckwalter, III Victor L. Lund Clifton H. Morris, Jr. Thomas L. Ryan Meetings In 2009 None |
Has authority to exercise many of the
powers of the full Board between Board meetings.
Is available to meet in circumstances where it is impractical to call a meeting of the full Board and there is urgency for Board discussion and decision-making on a specific issue. |
|
16
Change in Pension |
|||||||||||||||||||||||||
Value and |
|||||||||||||||||||||||||
Nonqualified |
|||||||||||||||||||||||||
Fees Earned |
Deferred |
||||||||||||||||||||||||
or Paid |
Stock |
Compensation |
All Other |
||||||||||||||||||||||
Name | in Cash | Awards(1) | Earnings(2) | Compensation(3) | Total | ||||||||||||||||||||
Alan R. Buckwalter, III
|
$ | 104,250 | $ | 52,050 | NA | $ | 23,059 | $ | 179,359 | ||||||||||||||||
Anthony L. Coelho
|
95,750 | 52,050 | $ | 18,459 | 0 | 166,259 | |||||||||||||||||||
A.J. Foyt
|
52,500 | 52,050 | 32,393 | 9,272 | 146,215 | ||||||||||||||||||||
Malcolm Gillis
|
95,750 | 52,050 | NA | 19,116 | 166,916 | ||||||||||||||||||||
Victor L. Lund
|
103,750 | 52,050 | NA | 78,633 | 234,433 | ||||||||||||||||||||
John W. Mecom, Jr.
|
91,750 | 52,050 | 36,428 | 31,317 | 211,545 | ||||||||||||||||||||
Clifton H. Morris, Jr.
|
87,000 | 52,050 | 16,793 | 19,026 | 174,869 | ||||||||||||||||||||
W. Blair Waltrip
|
67,000 | 52,050 | NA | 41,452 | 160,502 | ||||||||||||||||||||
Edward E. Williams
|
103,000 | 52,050 | 18,286 | 0 | 173,336 | ||||||||||||||||||||
(1) | Amounts in the Stock Awards column represent the fair market value of each award on the date of grant. Specifically, the value was calculated by multiplying (i) the average of the high and low market prices of a share of common stock of SCI on the date of the grant of the stock award, by (ii) 10,000 shares, which was the number of SCI shares per award. | |
(2) | Amounts in this column include increases in the actuarial present values of benefits as discussed under Directors Retirement Plan below. | |
(3) | Amounts in this column are discussed under Use of Company Aircraft below. With respect to Mr. W. Blair Waltrip, the amount in this column consists of a $21,390 premium paid by the Company for split dollar insurance, plus a tax gross up of $12,268, to which Mr. Waltrip is entitled in connection with his service as a former executive officer of the Company. |
17
18
| align executive pay and benefits with the performance of the Company and shareholder returns; and | |
| attract, motivate, reward and retain the broad-based management talent required to achieve our corporate directives. |
| reviews appropriate criteria for establishing performance targets for executive compensation; | |
| determines appropriate levels of executive compensation by annually conducting a thorough competitive evaluation, reviewing proprietary and proxy information, and consulting with and receiving advice from an independent executive compensation consulting firm; | |
| ensures that the Companys executive stock plan, long-term incentive plan, annual incentive compensation plan and other executive compensation plans are administered in accordance with compensation objectives; and | |
| approves all new equity-based compensation programs. |
| annual base salaries; | |
| annual performance-based incentives paid in cash; | |
| long-term performance-based incentives delivered in stock options, restricted stock and performance units; and | |
| retirement plans providing for financial security. |
19
Long-Term Incentive Compensation |
Restricted Stock |
Objective: Supports
retention and encourages stock ownership
|
|||
Performance Units |
Objective: Rewards for
effective management of Company business over a multi-year period
|
||||
Stock Options |
Objective: Rewards for
the Companys stock price appreciation
|
||||
Annual Cash
Compensation |
Annual Performance- Based Incentives |
Objective: Rewards
achievement of shorter term financial and operational objectives
that we believe are primary drivers of our common stock price
over time
|
|||
Base Salary |
Objective: Serves to
attract and retain executive talent and may vary with individual
or due to marketplace competition or economic conditions
|
||||
20
21
| Normalized Earnings Per Share, which we define as the Companys fully-diluted earnings per share calculated in accordance with US Generally Accepted Accounting Principles for the measurement period as reported in the Companys financial results utilizing a 33.5% effective tax rate. The earnings per share for such bonus calculation is adjusted to exclude the following: |
| Consolidated Free Cash Flow, which we calculate by adjusting Cash Flows from Operating Activities calculated in accordance with US Generally Accepted Accounting Principles by: |
(1) | Excluding: |
(a) | Cash federal and state income taxes paid relating to gains on sale of businesses or real estate | |
(b) | Cash payments associated with major litigation settlements | |
(c) | Accounting charges or expenses relating to acquisitions | |
(d) | Variances from forecasted cash taxes related to normal operating earnings |
(2) | Deducting capital improvements at existing facilities and capital expenditures to develop cemetery property |
| Comparable Revenue Growth, which we define as the percentage change from the prior year in total revenue for combined funeral and cemetery comparable same-store locations in North America. | |
| Comparable Sales Production Growth, which we define as the percentage change from the prior year in combined total preneed funeral sales production, total preneed cemetery sales production and total at need cemetery sales production at comparable same-store locations in North America. |
22
| Comparable Division Revenue Growth, which we define as Comparable Revenue Growth of the locations in Mr. Warings division. | |
| Comparable Division Sales Production Growth, which we define as Comparable Sales Production Growth of the locations in Mr. Warings division. |
23
Target Award |
||||
(% of Base Salary) | ||||
R.L. Waltrip
|
100 | % | ||
Thomas L. Ryan
|
110 | % | ||
Michael R. Webb
|
100 | % | ||
Eric D. Tanzberger
|
60 | % | ||
Sumner J. Waring, III
|
60 | % |
24
2010 Grants | ||||||||||||
Stock Options |
Restricted Stock |
Performance Units |
||||||||||
Name
|
Grant (Shares) | Grant (Shares) | Grant (Units) | |||||||||
R. L. Waltrip
|
231,000 | 69,400 | 889,000 | |||||||||
Thomas L. Ryan
|
434,000 | 130,000 | 1,670,000 | |||||||||
Michael R. Webb
|
202,000 | 60,700 | 778,000 | |||||||||
Eric D. Tanzberger
|
79,500 | 23,800 | 306,000 | |||||||||
Sumner J. Waring, III
|
79,500 | 23,800 | 306,000 |
25
| The actual annual performance-based incentive paid in cash to the officer, but only if the original payment would have been lower if it had been based on the restated financial results. | |
| The gains from sales of stock acquired under stock options realized at any time after the filing of the incorrect financial statements. (Any remaining vested and unvested stock options would be cancelled). | |
| The gains from sales of restricted stock realized at any time after the filing of the incorrect financial statements. (Any remaining unvested restricted stock would be forfeited). | |
| The amount of a performance unit award paid after the ending date of the period covered by the incorrect financial statements. (Any unpaid performance unit award would be forfeited). |
Target Holdings |
||||
Title
|
(# of Shares) | |||
Chairman of the Board
|
400,000 | |||
President and Chief Executive Officer
|
400,000 | |||
Executive Vice President and Chief Operating Officer
|
200,000 | |||
Senior Vice President
|
100,000 | |||
Vice President
|
40,000 |
26
7.5% Retirement |
Performance |
|||||||||||
Name
|
Contribution | Contribution | Total | |||||||||
R.L. Waltrip
|
NA | NA | N/A | |||||||||
Thomas L. Ryan
|
$ | 174,589 | $ | 277,014 | $ | 451,603 | ||||||
Michael R. Webb
|
116,393 | 184,676 | 301,069 | |||||||||
Eric D. Tanzberger
|
58,557 | 92,910 | 151,467 | |||||||||
Sumner J. Waring, III
|
57,462 | 91,173 | 148,635 |
| club memberships For 2010, the Compensation Committee decided to eliminate reimbursement of monthly dues for club memberships. Prior to 2010, we reimbursed such monthly dues. | |
| financial and legal planning and tax preparation provided to officers to encourage critical document preparation and financial planning advice for effective tax and retirement planning |
27
| supplemental medical reimbursements provided to officers and managing directors. The insured benefit product covers out of pocket medical expenses, exclusive of required premium contributions by participants in the Companys medical and dental plans, and is a valued benefit provided at modest annual cost per participant. | |
| enhanced long-term disability policy protects the officer in the event of a long-term disability determination, replacing 60% of the executives annual cash compensation in the event of disability. | |
| enhanced life insurance executive life insurance program for officers covering 3.5 times the executives annual salary and bonus. | |
| funeral and cemetery benefits provides funeral/cemetery discounts for directors and officers and their immediate families, on an atneed or prearranged basis. Under the policy, the Company provides (i) services free of cost, and (ii) merchandise, property and interment rights at cost. | |
| security and transportation services provided to the Chairman of the Board as approved by the Compensation Committee | |
| personal use of Company aircraft officers are entitled to certain hours of use of the Companys leased or financed aircraft for personal reasons in accordance with the Companys usage policy approved by the Board of Directors and pursuant to a signed time-sharing agreement which is governed by FAA regulations. Each officer is required to sign the time-sharing agreement. In accordance with the agreement, officers are required to reimburse the Company for operating costs associated with personal aircraft usage which are based on an hourly rate and include estimates for costs that are specifically defined by the FAA regulations pursuant to time-sharing agreements. Catering and pilot travel expenses are charged as incurred. Hours allowed are based on title and approved by the Board. Such personal use is treated as taxable compensation to the executive to the extent the IRS valuation of the personal aircraft usage exceeds the value submitted to the Company from the executive pursuant to the time-sharing agreement. |
28
Change in |
||||||||||||||||||||||||||||||||||||||||||
Pension Value |
||||||||||||||||||||||||||||||||||||||||||
and Nonqualified |
||||||||||||||||||||||||||||||||||||||||||
Restricted |
Non-Equity |
Deferred |
||||||||||||||||||||||||||||||||||||||||
Name and |
Stock |
Option |
Incentive Plan |
Compensation |
All Other |
|||||||||||||||||||||||||||||||||||||
Principal Position | Year | Salary | Awards(1) | Awards(1) | Compensation(2) | Earnings(3) | Compensation(4) | Total | ||||||||||||||||||||||||||||||||||
R. L. Waltrip
|
2009 | $ | 950,000 | $ | 493,830 | $ | 491,652 | $ | 1,507,175 | 0 | $ | 546,161 | $ | 3,988,818 | ||||||||||||||||||||||||||||
Chairman of the Board
|
2008 | 950,000 | $ | 567,485 | $ | 856,080 | 0 | 0 | $ | 596,268 | $ | 2,969,833 | ||||||||||||||||||||||||||||||
2007 | 950,000 | 605,172 | 974,400 | $ | 2,860,650 | 0 | 646,402 | 6,036,624 | ||||||||||||||||||||||||||||||||||
Thomas L. Ryan
|
2009 | $ | 900,000 | $ | 832,815 | $ | 829,587 | $ | 1,427,850 | $ | 22,001 | 215,247 | 4,227,500 | |||||||||||||||||||||||||||||
President and Chief
|
2008 | 900,000 | 958,573 | 1,446,480 | 0 | 46 | 822,014 | 4,127,113 | ||||||||||||||||||||||||||||||||||
Executive Officer
|
2007 | 898,076 | 1,137,380 | 1,827,000 | 2,970,100 | 5,247 | 717,409 | 7,555,212 | ||||||||||||||||||||||||||||||||||
Michael R. Webb
|
2009 | 600,000 | 385,020 | 384,119 | 951,900 | 54,704 | 191,351 | 2,567,094 | ||||||||||||||||||||||||||||||||||
Executive Vice President
|
2008 | 600,000 | 443,311 | 669,120 | 0 | 4,906 | 594,601 | 2,311,938 | ||||||||||||||||||||||||||||||||||
and Chief Operating Officer
|
2007 | 599,519 | 567,617 | 913,500 | 1,859,600 | 18,343 | 582,168 | 4,540,747 | ||||||||||||||||||||||||||||||||||
Eric D. Tanzberger
|
2009 | 400,000 | 161,541 | 161,342 | 380,760 | 11,857 | 100,287 | 1,215,787 | ||||||||||||||||||||||||||||||||||
Senior Vice President
|
2008 | 399,424 | 186,841 | 280,932 | 0 | 0 | 261,915 | 1,129,112 | ||||||||||||||||||||||||||||||||||
and Chief Financial Officer
|
2007 | 373,558 | 226,403 | 365,400 | 571,875 | 2,939 | 234,004 | 1,774,179 | ||||||||||||||||||||||||||||||||||
Sumner J. Waring, III
|
2009 | 375,000 | 154,008 | 153,630 | 391,163 | 0 | 152,566 | 1,226,367 | ||||||||||||||||||||||||||||||||||
Senior Vice President
|
2008 | 375,000 | 160,149 | 241,079 | 0 | 0 | 281,907 | 1,058,135 | ||||||||||||||||||||||||||||||||||
Operations
|
2007 | 375,000 | 226,403 | 365,400 | 741,600 | 1,017 | 218,689 | 1,928,109 | ||||||||||||||||||||||||||||||||||
(1) | The Restricted Stock Awards and Option Awards columns set forth the aggregate grant date fair value computed in accordance with FASB ASC Topic 718. The assumptions made for the valuation of the awards are set forth in note 14 to the consolidated financial statements included in the SCI 2009 Annual Report on Form 10-K. | |
(2) | The Non-Equity Incentive Plan Compensation is composed of the following: |
Annual Performance-Based |
||||||||||||
Year | Incentive Paid in Cash | Performance Units(a) | ||||||||||
R.L. Waltrip
|
2009 | $ | 1,507,175 | 0 | ||||||||
2008 | 0 | 0 | ||||||||||
2007 | 1,735,650 | $ | 1,125,000 | |||||||||
Thomas L. Ryan
|
2009 | 1,427,850 | 0 | |||||||||
2008 | 0 | 0 | ||||||||||
2007 | 1,644,300 | 1,325,800 | ||||||||||
Michael R. Webb
|
2009 | 951,900 | 0 | |||||||||
2008 | 0 | 0 | ||||||||||
2007 | 1,096,200 | 763,400 | ||||||||||
Eric D. Tanzberger
|
2009 | 380,760 | 0 | |||||||||
2008 | 0 | 0 | ||||||||||
2007 | 411,075 | 160,800 | ||||||||||
Sumner J. Waring, III
|
2009 | 391,163 | 0 | |||||||||
2008 | 0 | 0 | ||||||||||
2007 | 380,000 | 361,600 |
29
(a) | Performance Units for 2009 related to the performance period of 2007-2009, Performance Units payments for 2008 were for the performance period of 2006-2008, and Performance Units payments for 2007 were for the performance period of 2005-2007. |
(3) | This column sets forth the change in the actuarial present value of each executives accumulated benefit in 2009, 2008 and 2007 for the following plans: |
Supplemental Executive |
||||||||||||
Retirement Plan for |
||||||||||||
Year | Cash Balance Plan | Senior Officers | ||||||||||
R.L. Waltrip.
|
2009 | 0 | 0 | |||||||||
2008 | 0 | 0 | ||||||||||
2007 | 0 | 0 | ||||||||||
Thomas L. Ryan
|
2009 | 0 | $ | 22,001 | ||||||||
2008 | 0 | 46 | ||||||||||
2007 | $ | 1,410 | 3,837 | |||||||||
Michael R. Webb
|
2009 | 0 | 54,704 | |||||||||
2008 | 0 | 4,906 | ||||||||||
2007 | 4,825 | 13,518 | ||||||||||
Eric D. Tanzberger
|
2009 | 0 | 11,857 | |||||||||
2008 | 0 | 0 | ||||||||||
2007 | 1,081 | 1,858 | ||||||||||
Sumner J. Waring
|
2009 | 0 | 0 | |||||||||
2008 | 0 | 0 | ||||||||||
2007 | 1,017 | 0 |
30
Perquisites | |||||||||||||||||||||||||||||||||||||||||||||||||
Contributions |
|||||||||||||||||||||||||||||||||||||||||||||||||
To Deferred |
Contributions |
Life |
Personal |
Medical |
Club |
||||||||||||||||||||||||||||||||||||||||||||
Compensation |
to 401(k) |
Insurance |
Disability |
Use of |
Financial |
Reimburse- |
Member- |
||||||||||||||||||||||||||||||||||||||||||
Name | Plan(a) | Plan(a) | Related(b) | Insurance(c) | Aircraft(d) | Planning(e) | ment(f) | ships(g) | Other(h) | ||||||||||||||||||||||||||||||||||||||||
R. L. Waltrip
|
$ | 18,375 | $ | 195,462 | $ | 127,067 | $ | 28,000 | $ | 18,107 | $ | 159,150 | |||||||||||||||||||||||||||||||||||||
Thomas L. Ryan
|
$ | 120,285 | 18,375 | 7,786 | $ | 12,719 | 37,166 | 5,686 | 11,649 | $ | 1,581 | ||||||||||||||||||||||||||||||||||||||
Michael R. Webb
|
73,549 | 18,375 | 10,691 | 18,232 | 55,166 | 3,550 | 8,548 | 3,240 | |||||||||||||||||||||||||||||||||||||||||
Eric D. Tanzberger
|
43,028 | 18,375 | 2,126 | 0 | 10,464 | 1,823 | 21,079 | 3,392 | |||||||||||||||||||||||||||||||||||||||||
Sumner J. Waring, III
|
38,421 | 18,375 | 2,224 | 4,323 | 75,700 | 4,700 | 7,383 | 1,440 | |||||||||||||||||||||||||||||||||||||||||
(a) | The amounts represent contributions by the Company to the accounts of executives in the plans identified in the table. The column Contributions to Deferred Compensation Plan also includes associated FICA tax gross up amounts as follows: |
Amount | ||||
R.L. Waltrip
|
0 | |||
Thomas L. Ryan
|
$ | 3,660 | ||
Michael R. Webb
|
1,924 | |||
Eric D. Tanzberger
|
1,403 | |||
Sumner J. Waring, III
|
546 |
(b) | For Mr. Waltrip the amount in this column represents $188,262 for reimbursement of life insurance premium and related taxes for split dollar life insurance and $7,200 for term life insurance premiums. For the other executives, the amounts represent payment for term life insurance premiums or supplemental life insurance. | |
(c) | The amounts represent the costs of premiums for enhanced long-term disability insurance. | |
(d) | The amounts represent the incremental cost of personal use of Company aircraft to the extent not reimbursed by the executive to the Company. The cost includes the average cost of fuel used, direct costs incurred such as flight planning services and food, and an hourly charge for maintenance of engine and airframe. For each flight, the executive must reimburse the Company at an hourly rate pursuant to a time-sharing agreement governed by FAA Regulations. The amounts reflected in the table above are the total incremental costs reduced by the amounts of such executive reimbursements. | |
(e) | The amounts represent payments by the Company for tax and financial planning services incurred by the executives. | |
(f) | The amounts represent payments by the Company to the executive for medical expenses which are incurred but which are not reimbursed to the executive by the Companys health insurance. | |
(g) | The amounts represent the costs of club memberships, excluding initiation fees, food service and general assessments. This perquisite has been terminated effective January 1, 2010. | |
(h) | For Mr. Waltrip, the amount in this column represents the costs of providing for him an automobile ($26,587), personal security and driving services of employees ($53,754) and guard and alarm services at his residence ($78,809). |
31
All Other |
All Other |
Exercise |
Closing |
|||||||||||||||||||||||||||||||||||||||||||||||||||
Estimated Future Payouts |
Restricted |
Option Awards: |
or Base |
Market |
Grant Date |
|||||||||||||||||||||||||||||||||||||||||||||||||
Under Non-Equity Incentive Plan Awards |
Stock Awards: |
Number of |
Price of |
Price on |
Fair Value |
|||||||||||||||||||||||||||||||||||||||||||||||||
Number of |
Securities |
Option |
Date of |
of Stock |
||||||||||||||||||||||||||||||||||||||||||||||||||
Grant |
Performance |
Threshold |
Target |
Maximum |
Shares |
Underlying |
Awards |
Grant |
and Option |
|||||||||||||||||||||||||||||||||||||||||||||
Name | Date | units (#) | ($) | ($) | ($) | of Stock | Options | ($/Sh) | ($/Sh) | Awards ($) | ||||||||||||||||||||||||||||||||||||||||||||
R. L. Waltrip
|
02/10/2009 | $ | 1 | $ | 950,000 | $ | 1,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||
02/10/2009 | 533,300 | 133,325 | 533,300 | 1,066,600 | ||||||||||||||||||||||||||||||||||||||||||||||||||
02/10/2009 | 118,000 | $ | 493,830 | |||||||||||||||||||||||||||||||||||||||||||||||||||
02/10/2009 | 567,400 | $ | 4.185 | $ | 4.15 | 491,652 | ||||||||||||||||||||||||||||||||||||||||||||||||
Thomas L. Ryan
|
02/10/2009 | 1 | 900,000 | 1,800,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
02/10/2009 | 900,000 | 225,000 | 900,000 | 1,800,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
02/10/2009 | 199,000 | 832,815 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
02/10/2009 | 957,400 | 4.185 | 4.15 | 829,587 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Michael R. Webb
|
02/10/2009 | 1 | 600,000 | 1,200,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
02/10/2009 | 416,700 | 104,175 | 416,700 | 833,400 | ||||||||||||||||||||||||||||||||||||||||||||||||||
02/10/2009 | 92,000 | 385,020 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
02/10/2009 | 443,300 | 4.185 | 4.15 | 384,119 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Eric D. Tanzberger
|
02/10/2009 | 1 | 240,000 | 480,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
02/10/2009 | 175,000 | 43,750 | 175,000 | 350,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
02/10/2009 | 38,600 | 161,541 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
02/10/2009 | 186,200 | 4.185 | 4.15 | 161,342 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Sumner J. Waring, III
|
02/10/2009 | 1 | 225,000 | 450,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
02/10/2009 | 166,700 | 41,675 | 166,700 | 333,400 | ||||||||||||||||||||||||||||||||||||||||||||||||||
02/10/2009 | 36,800 | 154,008 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
02/10/2009 | 177,300 | 4.185 | 4.15 | 153,630 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| First line Annual Performance-Based Incentives Paid in Cash | |
| Second line Performance Units | |
| Third line Restricted Stock | |
| Fourth line Stock Options |
32
Option Awards | Stock Awards | |||||||||||||||||||||||
Market |
||||||||||||||||||||||||
Number of |
Value of |
|||||||||||||||||||||||
Shares or |
Shares or |
|||||||||||||||||||||||
Number of |
Number of |
Units of |
Units of |
|||||||||||||||||||||
Securities |
Securities |
Stock |
Stock |
|||||||||||||||||||||
Underlying |
Underlying |
Option |
That |
That |
||||||||||||||||||||
Unexercised |
Unexercised |
Exercise |
Option |
Have Not |
Have Not |
|||||||||||||||||||
Options |
Options |
Price |
Expiration |
Vested(4) |
Vested |
|||||||||||||||||||
Name
|
(#) | (#) | ($) | Date | (#) | ($) | ||||||||||||||||||
Exercisable | Unexercisable | |||||||||||||||||||||||
R.L. Waltrip
|
169,400 | $ | 1,387,386 | |||||||||||||||||||||
102,000 | 6.8050 | 02/10/2012 | ||||||||||||||||||||||
150,200 | 6.9000 | 02/08/2013 | ||||||||||||||||||||||
189,400 | 8.2400 | 02/07/2014 | ||||||||||||||||||||||
149,333 | 74,667 | (1) | 10.7300 | 02/13/2015 | ||||||||||||||||||||
58,000 | 116,000 | (2) | 11.6050 | 02/12/2016 | ||||||||||||||||||||
567,400 | (3) | 4.1850 | 02/10/2017 | |||||||||||||||||||||
Thomas L. Ryan
|
289,401 | 2,370,194 | ||||||||||||||||||||||
100,000 | 2.9250 | 08/14/2010 | ||||||||||||||||||||||
57,500 | 6.8050 | 02/10/2012 | ||||||||||||||||||||||
177,000 | 6.9000 | 02/08/2013 | ||||||||||||||||||||||
260,400 | 8.2400 | 02/07/2014 | ||||||||||||||||||||||
280,000 | 140,000 | (1) | 10.7300 | 02/13/2015 | ||||||||||||||||||||
98,000 | 196,000 | (2) | 11.6050 | 02/12/2016 | ||||||||||||||||||||
957,400 | (3) | 4.1850 | 02/10/2017 | |||||||||||||||||||||
Michael R. Webb
|
135,101 | 1,106,477 | ||||||||||||||||||||||
100,000 | 2.9250 | 08/14/2010 | ||||||||||||||||||||||
46,000 | 6.8050 | 02/10/2012 | ||||||||||||||||||||||
101,900 | 6.9000 | 02/08/2013 | ||||||||||||||||||||||
118,400 | 8.2400 | 02/07/2014 | ||||||||||||||||||||||
140,000 | 70,000 | (1) | 10.7300 | 02/13/2015 | ||||||||||||||||||||
45,333 | 90,667 | (2) | 11.6050 | 02/12/2016 | ||||||||||||||||||||
443,300 | (3) | 4.1850 | 02/10/2017 | |||||||||||||||||||||
33
Option Awards | Stock Awards | |||||||||||||||||||||||
Market |
||||||||||||||||||||||||
Number of |
Value of |
|||||||||||||||||||||||
Shares or |
Shares or |
|||||||||||||||||||||||
Number of |
Number of |
Units of |
Units of |
|||||||||||||||||||||
Securities |
Securities |
Stock |
Stock |
|||||||||||||||||||||
Underlying |
Underlying |
Option |
That |
That |
||||||||||||||||||||
Unexercised |
Unexercised |
Exercise |
Option |
Have Not |
Have Not |
|||||||||||||||||||
Options |
Options |
Price |
Expiration |
Vested(4) |
Vested |
|||||||||||||||||||
Name
|
(#) | (#) | ($) | Date | (#) | ($) | ||||||||||||||||||
Exercisable | Unexercisable | |||||||||||||||||||||||
Eric D. Tanzberger
|
56,368 | 461,654 | ||||||||||||||||||||||
12,500 | 6.8050 | 02/10/2012 | ||||||||||||||||||||||
41,400 | 8.2400 | 02/07/2014 | ||||||||||||||||||||||
56,000 | 28,000 | (1) | 10.7300 | 02/13/2015 | ||||||||||||||||||||
19,033 | 38,067 | (2) | 11.6050 | 02/12/2016 | ||||||||||||||||||||
186,200 | (3) | 4.1850 | 02/10/2017 | |||||||||||||||||||||
Sumner J. Waring, III
|
25,500 | 6.8050 | 02/10/2012 | 53,034 | 434,348 | |||||||||||||||||||
53,200 | 8.2400 | 02/07/2014 | ||||||||||||||||||||||
56,000 | 28,000 | (1) | 10.730 | 02/13/2015 | ||||||||||||||||||||
16,333 | 32,667 | (2) | 11.6050 | 02/12/2016 | ||||||||||||||||||||
177,300 | (3) | 4.1850 | 02/10/2017 | |||||||||||||||||||||
(1) | These unexercisable options expiring on 02/13/2015 vest 100% on 02/13/2010. | |
(2) | These unexercisable options expiring 02/12/2016 vest 50% on 02/12/2010 and 50% on 02/12/2011. | |
(3) | These unexercisable options expiring 02/12/2017 vest 331/3% on each of 02/12/2010, 02/12/2011 and 02/12/2012. | |
(4) | The restricted stock for each person in the table vests as follows: |
Shares |
Shares |
Shares |
Shares |
Shares |
||||||||||||||||
Vesting |
Vesting |
Vesting |
Vesting |
Vesting |
||||||||||||||||
02/15/2010
|
03/05/2010 | 02/15/2011 | 03/05/2011 | 03/05/2012 | ||||||||||||||||
R.L. Waltrip
|
35,100 | 39,333 | 16,300 | 39,333 | 39,333 | |||||||||||||||
Thomas L. Ryan
|
62,867 | 66,333 | 27,534 | 66,333 | 66,334 | |||||||||||||||
Michael R. Webb
|
30,367 | 30,666 | 12,734 | 30,667 | 30,667 | |||||||||||||||
Eric D. Tanzberger
|
12,401 | 12,866 | 5,367 | 12,867 | 12,867 | |||||||||||||||
Sumner J. Waring, III
|
11,634 | 12,266 | 4,600 | 12,267 | 12,267 |
Option Awards | Stock Awards | |||||||||||||||
Number of Shares |
Value Realized on |
Number of Shares |
Value Realized |
|||||||||||||
Acquired on |
Exercise |
Acquired on |
on Vesting |
|||||||||||||
Name
|
Exercise (#) | ($) | Vesting (#) | ($) | ||||||||||||
R.L. Waltrip
|
1,000,000 | $ | 2,027,599 | 58,500 | $ | 253,890 | ||||||||||
Thomas L. Ryan
|
100,000 | 246,379 | 95,032 | 409,955 | ||||||||||||
Michael R. Webb
|
100,000 | 248,668 | 45,000 | 193,870 | ||||||||||||
Eric D. Tanzberger
|
100,000 | 184,431 | 17,533 | 75,295 | ||||||||||||
Sumner J. Waring, III
|
0 | 0 | 18,199 | 78,681 |
34
Number of Years |
Present Value of |
Payments During |
||||||||||||||
Credited Service |
Accumulated Benefit |
Last Fiscal Year |
||||||||||||||
Name
|
Plan Name | (#) | ($)(1) | ($)(2) | ||||||||||||
R. L. Waltrip
|
SERP for Sr. Officers | NA | $ | 0 | 0 | |||||||||||
Thomas L. Ryan
|
SERP for Sr. Officers | 14 | 92,618 | 0 | ||||||||||||
Michael R. Webb
|
SERP for Sr. Officers | 20 | 308,227 | 0 | ||||||||||||
Eric D. Tanzberger
|
SERP for Sr. Officers | 13 | 45,795 | 0 | ||||||||||||
Sumner J. Waring, III
|
SERP for Sr. Officers | NA | 0 | 0 |
(1) | The assumptions made for calculating the present value of accumulated benefit of the SERP for Sr. Officers are set forth in note 15 to the consolidated financial statements included in the SCI 2009 Annual Report on Form 10-K. |
35
Executive |
Registrant |
Aggregate |
Aggregate |
Aggregate |
||||||||||||||||
Contributions |
Contributions |
Earnings |
Withdrawals/ |
Balance at |
||||||||||||||||
in Last FY(1) |
in Last FY(2) |
in Last FY(3) |
Distributions |
Last FYE(4) |
||||||||||||||||
Name
|
($) | ($) | ($) | ($) | ($) | |||||||||||||||
R.L. Waltrip
|
NA | NA | NA | NA | NA | |||||||||||||||
Thomas L. Ryan
|
$ | 90,000 | $ | 116,625 | $ | 685,166 | 0 | $ | 3,271,506 | |||||||||||
Michael R. Webb
|
36,000 | 71,625 | 292,783 | 0 | 2,416,766 | |||||||||||||||
Eric D. Tanzberger
|
24,000 | 41,625 | 142,413 | 0 | 753,098 | |||||||||||||||
Sumner J. Waring, III
|
22,500 | 37,875 | 144,870 | 0 | 794,673 |
(1) | These executive contributions were made in 2009 and are included in the Summary Compensation Table for the year 2009 in the amounts and under the headings as follows: |
Salary | ||||
R.L. Waltrip
|
NA | |||
Thomas L. Ryan
|
$ | 90,000 | ||
Michael R. Webb
|
36,000 | |||
Eric D. Tanzberger
|
24,000 | |||
Sumner J. Waring, III
|
22,500 |
(2) | The registrant contributions are included in the Summary Compensation Table under the All Other Compensation column. | |
(3) | The earnings reflect the returns of the measurement funds selected by the executives and are not included in the Summary Compensation Table. | |
(4) | The Aggregate Balance at Last FYE includes amounts previously reported as compensation in the Summary Compensation Table for years prior to 2009 as follows: |
R.L. Waltrip
|
NA | |||
Thomas L. Ryan
|
$ | 3,278,089 | ||
Michael R. Webb
|
2,347,131 | |||
Eric D. Tanzberger
|
616,568 | |||
Sumner J. Waring, III
|
413,529 |
36
2009 Calendar |
||||
Fund Name
|
Year Return | |||
Davis Value
|
31.16 | % | ||
Fidelity VIP Contrafund
|
35.71 | |||
Fidelity VIP Index 500
|
26.61 | |||
Fidelity VIP Mid Cap
|
40.09 | |||
Fidelity VIP Overseas
|
26.53 | |||
Janus Aspen Enterprise Portfolio
|
44.83 | |||
Janus Aspen Series Forty
|
46.33 | |||
LVIP Baron Growth Opportunities Fund
|
38.33 | |||
MainStay VP Cash Management
|
0.05 | |||
MainStay VP High Yield Corporate Bond
|
42.82 | |||
MainStay VP ICAP Select Equity
|
29.41 | |||
Morgan Stanley UIF Emerging Markets Debt
|
30.21 | |||
NYLIC General Account Fund
|
4.04 | |||
PIMCO VIT Real Return Bond
|
18.39 | |||
PIMCO VIT Total Return bond
|
14.07 | |||
Royce Small-Cap
|
35.20 | |||
T. Rowe Price Equity Income
|
25.60 | |||
T. Rowe Price Limited-Term Bond
|
8.30 |
37
| A lump sum equal to three, multiplied by the sum of the executives annual salary plus target annual performance-based incentive bonus (Target Bonus). | |
| An amount equal to his target annual performance-based incentive bonus, prorated to the date of the change of control (Partial Bonus). | |
| Continuation of health benefits for eighteen months. |
| Any individual, entity or group acquires 20 percent or more of our common stock or voting securities (excluding certain acquisitions involving SCI or an SCI benefit plan or certain reorganization, merger or consolidation transactions); |
38
| Our incumbent directors cease to constitute a majority of our directors (our incumbent directors include persons nominated by the existing Board or Executive Committee); | |
| Our shareholders approve certain reorganizations, mergers or consolidations; or | |
| Our shareholders approve certain liquidations, dissolutions or sales of substantially all assets of SCI. |
39
Change of |
|||||||||||||||||||||||||
Control: |
|||||||||||||||||||||||||
Involuntary |
Involuntary or |
||||||||||||||||||||||||
Executive Benefits and Payments |
Voluntary |
Not for Cause |
Good Reason |
||||||||||||||||||||||
Upon Termination as of 12-31-09 | Termination | Termination | Termination | Disability | Death | ||||||||||||||||||||
Compensation:
|
|||||||||||||||||||||||||
Base Salary
|
$ | 1,900,000 | $ | 2,850,000 | $ | 950,000 | $ | 950,000 | |||||||||||||||||
Annual Performance-Based Incentive Paid in Cash
|
|||||||||||||||||||||||||
Target Bonus
|
2,850,000 | ||||||||||||||||||||||||
Pro Rated Bonus
|
1,507,175 | 1,507,175 | 1,507,175 | ||||||||||||||||||||||
Partial Bonus
|
950,000 | ||||||||||||||||||||||||
Long Term Incentives
|
|||||||||||||||||||||||||
Performance Units
|
|||||||||||||||||||||||||
2007-2009
(performance period)
|
|||||||||||||||||||||||||
2008-2010
(performance period)
|
723,600 | ||||||||||||||||||||||||
2009-2011
(performance period)
|
355,533 | 355,533 | 533,300 | 355,533 | 355,533 | ||||||||||||||||||||
Stock Options
|
|||||||||||||||||||||||||
Unvested and Accelerated
|
$ | 1,686,643 | $ | 1,686,643 | $ | 1,686,643 | $ | 1,686,643 | $ | 1,686,643 | |||||||||||||||
Restricted Stock
|
|||||||||||||||||||||||||
Unvested and Accelerated
|
$ | 1,387,386 | 1,387,386 | 1,387,386 | 1,387,386 | 1,387,386 | |||||||||||||||||||
Other Benefits:
|
|||||||||||||||||||||||||
Nonqualified Deferred Compensation
|
|||||||||||||||||||||||||
Unvested and Accelerated
|
|||||||||||||||||||||||||
Post-retirement Health Care
|
23,264 | 23,264 | |||||||||||||||||||||||
Life Insurance Proceeds
|
1,450,000 | ||||||||||||||||||||||||
Disability Benefits
|
234,811 | ||||||||||||||||||||||||
280G Tax
Gross-up
|
0 | ||||||||||||||||||||||||
Total:
|
$ | 3,429,562 | $ | 6,860,001 | $ | 11,004,193 | $ | 6,121,548 | $ | 7,336,737 | |||||||||||||||
40
Change of |
|||||||||||||||||||||||||
Control: |
|||||||||||||||||||||||||
Involuntary |
Involuntary or |
||||||||||||||||||||||||
Executive Benefits and Payments |
Voluntary |
Not for Cause |
Good Reason |
||||||||||||||||||||||
Upon Termination as of 12-31-09 | Termination | Termination | Termination | Disability | Death | ||||||||||||||||||||
Compensation:
|
|||||||||||||||||||||||||
Base Salary
|
$ | 1,800,000 | $ | 2,700,000 | $ | 900,000 | $ | 900,000 | |||||||||||||||||
Annual Performance-Based Incentive Paid in Cash
|
|||||||||||||||||||||||||
Target Bonus
|
2,700,000 | ||||||||||||||||||||||||
Pro Rated Bonus
|
1,427,850 | 1,427,850 | 1,427,850 | ||||||||||||||||||||||
Partial Bonus
|
900,000 | ||||||||||||||||||||||||
Long Term Incentives
|
|||||||||||||||||||||||||
Performance Units
|
|||||||||||||||||||||||||
2007-2009
(performance period)
|
|||||||||||||||||||||||||
2008-2010
(performance period)
|
1,221,000 | ||||||||||||||||||||||||
2009-2011
(performance period)
|
600,000 | 900,000 | 600,000 | 600,000 | |||||||||||||||||||||
Stock Options
|
|||||||||||||||||||||||||
Unvested and Accelerated
|
2,809,447 | 2,809,447 | 2,809,447 | 2,809,447 | |||||||||||||||||||||
Restricted Stock
|
|||||||||||||||||||||||||
Unvested and Accelerated
|
2,370,194 | 2,370,194 | 2,370,194 | 2,370,194 | |||||||||||||||||||||
Other Benefits:
|
|||||||||||||||||||||||||
Nonqualified Deferred Compensation
|
|||||||||||||||||||||||||
Unvested and Accelerated
|
222,979 | 222,979 | 222,979 | 222,979 | |||||||||||||||||||||
Post-retirement Health Care
|
28,153 | 28,153 | |||||||||||||||||||||||
Life Insurance Proceeds
|
6,300,000 | ||||||||||||||||||||||||
Disability Benefits
|
15,019,280 | ||||||||||||||||||||||||
280G Tax
Gross-up
|
0 | ||||||||||||||||||||||||
Total:
|
$ | 9,258,623 | $ | 13,851,773 | $ | 23,349,750 | $ | 14,630,470 | |||||||||||||||||
41
Change of |
|||||||||||||||||||||||||
Control: |
|||||||||||||||||||||||||
Involuntary |
Involuntary or |
||||||||||||||||||||||||
Executive Benefits and Payments |
Voluntary |
Not for Cause |
Good Reason |
||||||||||||||||||||||
Upon Termination as of 12-31-09 | Termination | Termination | Termination | Disability | Death | ||||||||||||||||||||
Compensation:
|
|||||||||||||||||||||||||
Base Salary
|
$ | 1,200,000 | $ | 1,800,000 | $ | 600,000 | $ | 600,000 | |||||||||||||||||
Annual Performance-Based Incentive Paid in Cash
|
|||||||||||||||||||||||||
Target Bonus
|
1,800,000 | ||||||||||||||||||||||||
Pro Rated Bonus
|
951,900 | 951,900 | 951,900 | ||||||||||||||||||||||
Partial Bonus
|
600,000 | ||||||||||||||||||||||||
Long Term Incentives
|
|||||||||||||||||||||||||
Performance Units
|
|||||||||||||||||||||||||
2007-2009
(performance period)
|
|||||||||||||||||||||||||
2008-2010
(performance period)
|
565,300 | ||||||||||||||||||||||||
2009-2011
(performance period)
|
277,800 | 416,700 | 277,800 | 277,800 | |||||||||||||||||||||
Stock Options
|
|||||||||||||||||||||||||
Unvested and Accelerated
|
1,287,989 | 1,287,989 | 1,287,989 | 1,287,989 | |||||||||||||||||||||
Restricted Stock
|
|||||||||||||||||||||||||
Unvested and Accelerated
|
1,106,477 | 1,106,477 | 1,106,477 | 1,106,477 | |||||||||||||||||||||
Other Benefits:
|
|||||||||||||||||||||||||
Nonqualified Deferred Compensation
|
|||||||||||||||||||||||||
Unvested and Accelerated
|
159,613 | 159,613 | 159,613 | 159,613 | |||||||||||||||||||||
Post-retirement Health Care
|
28,153 | 28,153 | |||||||||||||||||||||||
Life Insurance Proceeds
|
4,310,000 | ||||||||||||||||||||||||
Disability Benefits
|
7,336,265 | ||||||||||||||||||||||||
280G Tax
Gross-up
|
0 | ||||||||||||||||||||||||
Total:
|
$ | 5,011,932 | $ | 7,764,232 | $ | 11,720,044 | $ | 8,693,779 | |||||||||||||||||
42
Change of |
|||||||||||||||||||||||||
Control: |
|||||||||||||||||||||||||
Involuntary |
Involuntary or |
||||||||||||||||||||||||
Executive Benefits and Payments |
Voluntary |
Not for Cause |
Good Reason |
||||||||||||||||||||||
Upon Termination as of 12-31-09 | Termination | Termination | Termination | Disability | Death | ||||||||||||||||||||
Compensation:
|
|||||||||||||||||||||||||
Base Salary
|
$ | 800,000 | $ | 1,200,000 | $ | 400,000 | $ | 400,000 | |||||||||||||||||
Annual Performance-Based Incentive Paid in Cash
|
|||||||||||||||||||||||||
Target Bonus
|
720,000 | ||||||||||||||||||||||||
Pro Rated Bonus
|
380,760 | 380,760 | 380,760 | ||||||||||||||||||||||
Partial Bonus
|
240,000 | ||||||||||||||||||||||||
Long Term Incentives
|
|||||||||||||||||||||||||
Performance Units
|
|||||||||||||||||||||||||
2007-2009
(performance period)
|
|||||||||||||||||||||||||
2008-2010
(performance period)
|
237,400 | ||||||||||||||||||||||||
2009-2011
(performance period)
|
116,667 | 175,000 | 116,667 | 116,667 | |||||||||||||||||||||
Stock Options
|
|||||||||||||||||||||||||
Unvested and Accelerated
|
544,612 | 544,612 | 544,612 | 544,612 | |||||||||||||||||||||
Restricted Stock
|
|||||||||||||||||||||||||
Unvested and Accelerated
|
461,654 | 461,654 | 461,654 | 461,654 | |||||||||||||||||||||
Other Benefits:
|
|||||||||||||||||||||||||
Nonqualified Deferred Compensation
|
|||||||||||||||||||||||||
Unvested and Accelerated
|
83,294 | 83,294 | 83,294 | 83,294 | |||||||||||||||||||||
Post-retirement Health Care
|
27,973 | 27,973 | |||||||||||||||||||||||
Life Insurance Proceeds
|
2,240,000 | ||||||||||||||||||||||||
Disability Benefits
|
5,885,817 | ||||||||||||||||||||||||
280G Tax
Gross-up
|
0 | ||||||||||||||||||||||||
Total:
|
$ | 2,414,960 | $ | 3,689,933 | $ | 7,872,804 | $ | 4,226,987 | |||||||||||||||||
43
Change of |
|||||||||||||||||||||||||
Control: |
|||||||||||||||||||||||||
Involuntary |
Involuntary or |
||||||||||||||||||||||||
Executive Benefits and Payments |
Voluntary |
Not for Cause |
Good Reason |
||||||||||||||||||||||
Upon Termination as of 12-31-09 | Termination | Termination | Termination | Disability | Death | ||||||||||||||||||||
Compensation:
|
|||||||||||||||||||||||||
Base Salary
|
$ | 750,000 | $ | 1,125,000 | $ | 375,000 | $ | 375,000 | |||||||||||||||||
Annual Performance-Based Incentive Paid in Cash
|
|||||||||||||||||||||||||
Target Bonus
|
675,000 | ||||||||||||||||||||||||
Pro Rated Bonus
|
391,163 | 391,163 | 391,163 | ||||||||||||||||||||||
Partial Bonus
|
225,000 | ||||||||||||||||||||||||
Long Term Incentives
|
|||||||||||||||||||||||||
Performance Units
|
|||||||||||||||||||||||||
2007-2009
(performance period)
|
|||||||||||||||||||||||||
2008-2010
(performance period)
|
203,500 | ||||||||||||||||||||||||
2009-2011
(performance period)
|
111,133 | 166,700 | 111,133 | 111,133 | |||||||||||||||||||||
Stock Options
|
|||||||||||||||||||||||||
Unvested and Accelerated
|
527,409 | 527,409 | 527,409 | 527,409 | |||||||||||||||||||||
Restricted Stock
|
|||||||||||||||||||||||||
Unvested and Accelerated
|
434,348 | 434,348 | 434,348 | 434,348 | |||||||||||||||||||||
Other Benefits:
|
|||||||||||||||||||||||||
Nonqualified Deferred Compensation
|
|||||||||||||||||||||||||
Unvested and Accelerated
|
76,844 | 76,844 | 76,844 | 76,844 | |||||||||||||||||||||
Post-retirement Health Care
|
28,153 | 28,153 | |||||||||||||||||||||||
Life Insurance Proceeds
|
2,100,000 | ||||||||||||||||||||||||
Disability Benefits
|
5,472,299 | ||||||||||||||||||||||||
280G Tax
Gross-up
|
0 | ||||||||||||||||||||||||
Total:
|
$ | 2,319,050 | $ | 3,461,954 | $ | 7,388,196 | $ | 4,015,897 | |||||||||||||||||
44
45
46
Amount |
||||||||
Name and Address |
Beneficially |
Percent |
||||||
of Beneficial Owner
|
Owned | of Class | ||||||
FMR LLC, Fidelity Management & Research Company,
Fidelity Advisor
Leveraged Company Stock Fund, Fidelity Leveraged Company Stock Fund and Edward C. Johnson, 3d |
36,602,714 | (1) | 14.5 | % | ||||
82 Devonshire Street
Boston, Massachusetts 02109 |
||||||||
Barrow, Hanley, Mewhinney & Strauss, Inc.
|
26,714,591 | (2) | 10.5 | % | ||||
2200 Ross Avenue, 31st Floor
Dallas, Texas 75201-2761 |
||||||||
Vanguard Windsor Funds Vanguard Windsor II
Fund 23-2439132
|
25,080,100 | (3) | 9.9 | % | ||||
(Windsor II)
|
||||||||
100 Vanguard Blvd
Malvern, Pennsylvania 19355 |
||||||||
Southeastern Asset Management, Inc., Longleaf Partners Small Cap
Fund and O. Mason Hawkins
|
14,909,616 | (4) | 5.9 | % | ||||
6410 Poplar Ave., Suite 900
Memphis, TN 38119 |
||||||||
BlackRock, Inc.
|
13,780,114 | (5) | 5.4 | % | ||||
40 East 52nd Street
New York, NY 10022 |
(1) | Based on a filing made by the named companies and person on February 16, 2010, which reported sole voting power for 584,420 shares, shared voting power for no shares, sole investment power for 36,602,714 shares and shared investment power for no shares. | |
(2) | Based on a filing made by Barrow, Hanley, Mewhinney & Strauss, Inc. on February 9, 2010, which reported sole voting power for 1,206,155 shares, shared voting power for 25,508,436 shares, sole investment power for 26,714,591 shares and shared investment power for no shares. BHMS has informed the Company that the shares reported in the table as beneficially owned by BHMS include all 25,080,100 shares reported in the table as beneficially owned by Windsor II, for whom BHMS is an investment manager. | |
(3) | Based on a filing made by the named fund on February 4, 2010, which reported sole voting power for 25,080,100 shares, shared voting power for no shares, sole investment power for no shares and shared investment power for no shares. BHMS has informed the Company that the shares reported in the table as beneficially owned by BHMS include all 25,080,100 shares reported in the table as beneficially owned by Windsor II, for whom BHMS is an investment manager. | |
(4) | Based on a filing made by the named companies and person on February 5, 2010, which reported sole voting power for no shares, shared voting power for 14,909,616 shares, sole investment power for 300,900 shares and shared investment power for 14,608,716 shares. | |
(5) | Based on a filing made by the named company on January 29, 2010, which reported sole voting power for 13,780,114 shares, shared voting power for no shares, sole investment power for 13,780,114 shares and shared investment power for no shares. |
47
Right to Acquire Ownership |
||||||||||||
Shares |
Under Options Exercisable |
Percent |
||||||||||
Name of Individual or Group
|
Owned | Within 60 Days | of Class | |||||||||
R. L. Waltrip
|
1,829,513 | (1) | 970,733 | 1.1 | % | |||||||
Thomas L. Ryan
|
885,011 | 1,430,033 | * | |||||||||
Michael R. Webb
|
517,862 | 714,732 | * | |||||||||
Eric D. Tanzberger
|
177,842 | 238,032 | * | |||||||||
Sumner J. Waring, III
|
291,571 | 254,466 | * | |||||||||
Alan R. Buckwalter
|
87,587 | (2) | | * | ||||||||
Anthony L. Coelho
|
100,727 | | * | |||||||||
A. J. Foyt, Jr.
|
195,553 | (3) | | * | ||||||||
Malcolm Gillis
|
54,697 | | * | |||||||||
Victor L. Lund
|
177,886 | | * | |||||||||
John W. Mecom, Jr.
|
100,199 | | * | |||||||||
Clifton H. Morris, Jr.
|
148,227 | (4) | | * | ||||||||
W. Blair Waltrip
|
1,705,828 | (5) | | * | ||||||||
Edward E. Williams
|
260,882 | | * | |||||||||
Executive Officers and Directors as a Group (24 persons)
|
6,912,336 | 5,066,518 | 4.6 | % |
* | Less than one percent | |
(1) | Includes 468,384 shares held in trusts under which Mr. R. L. Waltrips three children, as trustees, share voting and investment powers; Mr. R.L. Waltrip disclaims beneficial ownership of such shares. These shares are also included in the shares owned by Mr. W. Blair Waltrip. See Footnote (5). Also includes 470,133 shares held by trusts of which Mr. R. L. Waltrip is the trustee having sole voting and investment powers. | |
(2) | Includes 6,400 shares held by Mr. Buckwalter as custodian for family members. Mr. Buckwalter has sole voting and investment power for such shares and disclaims beneficial ownership of such shares. | |
(3) | Includes 17,885 shares held by Mr. Foyt as custodian for family members. Mr. Foyt has sole voting and investment power for such shares and disclaims beneficial ownership of such shares. Also includes 1,125 shares owned by Mr. Foyts wife. | |
(4) | Includes 4,034 shares owned by Mr. Morris wife. Mr. Morris disclaims beneficial ownership of such shares. | |
(5) | Includes 253,438 shares held in trusts for the benefit of Mr. W. Blair Waltrip, and 468,384 shares held in trusts under which Mr. W. Blair Waltrip, his brother and his sister are trustees and have shared voting and investment power and for which Mr. W. Blair Waltrip disclaims 2/3 beneficial ownership. Also includes 105,357 shares held by other family members or trusts, of which shares Mr. W. Blair Waltrip disclaims beneficial ownership. Of the shares attributable to the trusts, 468,384 shares are also included in the shares owned by Mr. R. L. Waltrip. See Footnote (1). Also includes 82,000 shares held by a charitable foundation of which Mr. W. Blair Waltrip is President. |
48
49
50
51
3M | ||||||
AAI Abbott Laboratories Accenture ACH Food Advanced Medical Optics Advanced Micro Devices ADVO Aerojet Air Products and Chemicals Alcatel USA Alcoa Alcon Laboratories Allergan Alliant Techsystems Alstom Power Altana Pharma Altria Group America Online American Airlines American Standard Ameron AMETEK Amgen Ann Taylor Stores Apple Computer Applied Materials ARAMARK ArvinMeritor Ashland AstraZeneca AT&T Austin Industries Automatic Data Processing Avaya Avery Dennison BAE Systems CNI Division Barnes Group Barrick Baxter International Bayer Bayer CropScience Beckman Coulter BellSouth Best Buy Big Lots Black & Decker Bob Evans Farms Boehringer Ingelheim Boeing Boston Scientific Bracco Diagnostics Brady Brinker International DuPont Eastman Chemical Eaton Purdue Pharma QLT QUALCOMM Qwest Communications Ralcorp Holdings Raytheon Revlon Reynolds American Reynolds and Reynolds Rich Products Rinker Materials Rio Tinto RISO Robert Bosch Roche Diagnostics Roche Palo Alto Rockwell Automation Rockwell Collins Rohm and Haas Russell Corporation S.C. Johnson Sabre Safeway Sanofi-Aventis |
eBay Ecolab EDS Elan Pharmaceuticals Eli Lilly EMC EMCOR Group Emdeon Emerson EnCana Oil & Gas USA Engelhard Equifax Fairchild Controls FANUC Robotics America FANUC Robotics America Federated Department Stores Fleetwood Enterprises Fluke Fluor Ford Forest Laboratories Fortune Brands Freightliner G&K Services Gap Gartner GATX Genentech General Dynamics General Mills General Motors Genzyme Georgia Gulf Gilead Sciences GlaxoSmithKline Goodrich Goodyear Tire & Rubber Gortons GROWMARK GTECH H.B. Fuller H.J. Heinz Haemonetics Harley-Davidson Harman International Industries Harsco Hasbro Hawaiian Telecom HBO Herbalife International of America Hercules Herman Miller Hershey Foods Hess Hewlett-Packard Hexcel Schering-Plough Schneider Electric Schwans Science Applications International Scotts Miracle-Gro Seagate Technology Sherwin-Williams Siemens Sigma-Aldrich Sirius Satellite Radio Sodexho Solvay America Solvay Pharmaceuticals Sonoco Products Sony Electronics Sports Authority Springs Global Sprint Nextel St. Jude Medical St. Lawrence Cement Standard Register Staples Starbucks Starwood Hotels & Resorts |
Hilton Hotels HNI Hoffmann-La Roche Honeywell Houghton Mifflin Hovnanian Enterprises AC/InterActive Corp IBM ICI Paints North America IDEX IKON Office Solutions IMS Health Ingersoll-Rand Intel InterContinental Hotels International Flavors & Fragrances International Paper International Truck & Engine Irving Oil Itochu International ITT Corporate ITT Defense ITT Motion and Flow Control J.C. Penney Company J.M. Smucker J.R. Simplot Jack in the Box Jacobs Engineering Jarden Corporation JM Family John Crane Johns-Manville Johnson & Johnson Johnson Controls Jostens Kaman Industrial Technologies KB Home Kellogg Kennametal Kerr-McGee Kimberly-Clark King Pharmaceuticals Kinross Gold Kohler Kraft Foods Lafarge North America Land OLakes Lear Lexmark International Lorillard Lucent Technologies Marriott International Martin Marietta Materials Mary Kay Masco McDermott Steelcase Sun Microsystems SunGard Data Systems Sunoco Syngenta TAP Pharmaceuticals Target TDS Telecom Terex Texas Instruments Textron Thomas & Betts Thomson Time Warner Time Warner Cable Toro Tupperware Tyco Electronics UCB Unilever United States Union Pacific Unisys United Parcel Service United States Cellular |
McDonalds McGraw-Hill MDS Laboratory Service MeadWestvaco Medco Health Solutions Media General MedImmune Medtronic Merck Meredith Metaldyne Methode Electronics Microsoft Milacron Millennium Pharmaceuticals Millipore Mine Safety Appliances Mission Foods Modine Manufacturing Molex Molson Coors Brewing Monaco Coach Motorola MSC Industrial Direct Nalco National Semiconductor National Starch & Chemical NCS Pearson Nestle USA NIKE Noranda Aluminum Norfolk Southern Nortel Networks Northrop Grumman Novartis Novartis Consumer Health Novartis Pharmaceuticals Novo Nordisk Pharmaceuticals Occidental Petroleum Omnova Solutions Organon Packaging Corporation of America Panasonic Corporation of North America Par Pharmaceutical Parker Hannifin Parsons PepsiCo PerkinElmer Pernod Ricard USA Pfizer Phelps Dodge Philips Electronics North America Plexus PPG Industries Procter & Gamble ProQuest United Stationers United Technologies USG Valero Energy Verizon Verizon Wireless Vertex Pharmaceuticals Viacom Vistar Visteon Vulcan Materials W.R. Grace Walt Disney Washington Group Waste Management Watson Pharmaceuticals Wendys International Westinghouse Savannah River Weyerhaeuser Wm. Wrigley Jr. Wyeth Xerox Yahoo! Yum! Brands |
A-1
A.O. Smith Aeropostale American Crystal Sugar AMETEK Armstrong World Industries Arysta LifeScience North America* Beckman Coulter Bio-Rad Laboratories Blyth Bob Evans Farms Brady Brown-Forman CACI International Callaway Golf Carlson Companies Carmeuse Lime & Stone* Carpenter Technology Catalent Pharma Solutions CDI Celgene Century Aluminum Cephalon CompuCom Systems* ConvaTec Convergys Covance Crown Castle Cubic Deluxe Dentsply Donaldson E.W. Scripps EMI Music* Endo Pharmaceuticals Equifax Exterran First Solar Frontier Airlines G&K Services GAF Materials Garmin GATX General Atomics GEO Group Getty Images GTECH* H.B. Fuller Harland Clarke* Hayes-Lemmerz Herman Miller HNI HNTB Horizon Lines Houghton Mifflin Hovnanian Enterprises Hunt Consolidated IDEXX Laboratories IMS Health Intercontinental Hotels* International Flavors & Fragrances International Game Technology Irvine Company J. Crew |
J.M. Smucker Jack in the Box JetBlue Kaman Industrial Technologies* Kansas City Southern KB Home Kimco Realty Kinross Gold* KLA-Tencor L.L. Bean Life Touch Magellan Midstream Partners Martin Marietta Materials Mary Kay McClatchy Metavante Technologies MetroPCS Communications Millipore Mine Safety Appliances MSC Industrial Direct New York Times Noranda Aluminum Novell Omnova Solutions Papa Johns Parametric Technology Perot Systems Plexus Polaris Industries PolyOne Purdue Pharma Quintiles R.H. Donnelley Ralcorp Holdings Rayonier Readers Digest Regal-Beloit RF Micro Devices Safety-Kleen Systems SAS Institute Schreiber Foods Schwans Sensata Technologies Shire Pharmaceuticals* Stantec* Steelcase Sundt Construction TeleTech Holdings Tellabs Teradata Terra Industries Thomas & Betts Timex Toro Tupperware United Rentals Universal Studios Orlando Viad Virgin Mobile USA W.R.Grace Watson Pharmaceuticals Zale |
B-1
Company
|
Ticke | Company | Ticker | |||||||||
Advanced Medical Optics
|
EYE | International Game Technology | IGT | |||||||||
Alexander & Baldwin
|
ALEX | Iron Mountain | IRM | |||||||||
American Crystal Sugar
|
N/A | Irvine Company | N/A | |||||||||
AMETEK
|
AME | J.M. Smucker | SJM | |||||||||
Ann Taylor Stores
|
ANN | Jack in the Box | JACK | |||||||||
Applera
|
ABI | Jostens | N/A | |||||||||
Appleton Papers
|
N/A | Kaman Industrial Technologies | N/A | |||||||||
Arbys Restaurant Group
|
N/A | Kennametal | KMT | |||||||||
Arysta LifeScience North America
|
N/A | Kerzner International | N/A | |||||||||
Barr Laboratories
|
BRL | KLA-Tencor | KLAC | |||||||||
Beckman Coulter
|
BEC | Magellan Midstream Partners | MMP | |||||||||
BIC
|
N/A | Makino | N/A | |||||||||
Biogen Idec
|
BIIB | Martin Marietta Materials | MLM | |||||||||
Bio-Rad Laboratories
|
BIO | Mary Kay | N/A | |||||||||
Blyth
|
BTH | McClatchy | MNI | |||||||||
Bob Evans Farms
|
BOBE | MDS Pharma Services | N/A | |||||||||
Bracco Diagnostics
|
N/A | Media General | MEG | |||||||||
Brady
|
BRC | Metavante Technologies | MV | |||||||||
Burger King
|
BKC | MetroPCS Communications | PCS | |||||||||
Carpenter Technology
|
CRS | Millipore | MIL | |||||||||
CashNetUSA
|
N/A | Monaco Coach | MNC | |||||||||
Catalent Pharma Solutions
|
N/A | Mueller Water Products | MWA | |||||||||
Celgene
|
CELG | National Semiconductor | NSM | |||||||||
Cephalon
|
CEPH | New York Times | NYT | |||||||||
Ceridian
|
CEN | Noranda Aluminum | N/A | |||||||||
Chesapeake
|
CHK | Nypro | N/A | |||||||||
COACH
|
COH | PerkinElmer | PKI | |||||||||
Convergys
|
CVG | PolyOne | POL | |||||||||
Crown Castle
|
CCI | Purdue Pharma | N/A | |||||||||
Cubic
|
CUB | Quintiles | N/A | |||||||||
Day & Zimmermann
|
N/A | Ralcorp Holdings | RAH | |||||||||
Deluxe
|
DLX | Rayonier | RYN | |||||||||
Dentsply
|
XRAY | Revlon | REV | |||||||||
Discovery Communications
|
DISCA | RF Micro Devices | RFMD | |||||||||
Donaldson
|
DCI | Rich Products | N/A | |||||||||
E.W. Scripps
|
SSP | Safety-Kleen Systems | N/A | |||||||||
Endo Pharmaceuticals
|
ENDP | SAS Institute | N/A | |||||||||
Equifax
|
EFX | Schreiber Foods | N/A | |||||||||
Exterran
|
EXH | Scotts Miracle Gro | SMG | |||||||||
Fleetwood Enterprises
|
N/A | Sensata Technologies | N/A | |||||||||
Flint Group USA
|
N/A | Shire Pharmaceuticals | N/A | |||||||||
G&K Services
|
GKSRA | Sigma-Aldrich | SIAL | |||||||||
GATX
|
GMT | Sirius Satellite Radio | SIRI | |||||||||
General Atomics
|
N/A | Smith & Nephew | N/A | |||||||||
GEO Group
|
GEO | Springs Global US | N/A | |||||||||
Getty Images
|
GYI | Stantec | STN | |||||||||
Greif
|
GEF | Steelcase | SCS | |||||||||
GTECH
|
GTK | Stewart & Stevenson | N/A | |||||||||
H.B. Fuller
|
FUL | TeleTech Holdings | TTEC | |||||||||
Harland Clarke
|
N/A | Teradata | TDC | |||||||||
Hayes-Lemmerz
|
HAYZ | Terra Industries | TRA | |||||||||
Hercules
|
HPC | Thomas & Betts | TNB | |||||||||
Herman Miller
|
MLHR | Toro | TIC | |||||||||
HNI
|
HNI | Tupperware | TUP | |||||||||
Hospira
|
HSP | Underwriters Laboratories | N/A | |||||||||
Houghton Mifflin
|
N/A | Uni-Select USA | N/A | |||||||||
Hunt Consolidated
|
N/A | Virgin Mobile USA | VM | |||||||||
IDEX
|
IEX | Vistar | N/A | |||||||||
IMS Health
|
RX | Vulcan Materials | VMC | |||||||||
International Flavors & Fragrances
|
IFF | Wendys International | WEN | |||||||||
C-1
A.O. Smith Corp. | HNI Corp. | |
Advanced Medical Optics Inc.
|
Hospira Inc. | |
Alexander & Baldwin Inc.
|
IDEX Corporation | |
Allergan Inc.
|
International Flavors & Fragrances Inc. | |
American Greetings Corp.
|
International Game Technology | |
Ann Taylor Stores Corp.
|
Invitrogen Corp. | |
Applera Corp-Applied Biosystems Group
|
Iron Mountain Inc. | |
Armstrong World Industries Inc.
|
||
Beckman Coulter Inc.
|
J.M. Smucker Co. (The) | |
Bob Evans Farms Inc.
|
Jack in the Box Inc. | |
Brady Corp.
|
Kaman Corp | |
Burger King Holdings Inc.
|
Kennametal Inc. | |
Callaway Golf Co.
|
King Pharmaceuticals Inc. | |
Carpenter Technology Corp.
|
Level 3 Communications Inc. | |
Celgene Corp.
|
Louisiana-Pacific Corp. | |
Cephalon Inc.
|
Magellan Midstream Partners LP | |
Chesapeake Corp.
|
Martin Marietta Materials Inc. | |
Cincinnati Bell Inc.
|
Media General Inc. | |
Coach Inc.
|
Millipore Corp. | |
Comfort Systems USA Inc.
|
MSC Industrial Direct Co. Inc. | |
Constar International Inc.
|
National Semiconductor Corp. | |
Cooper Tire & Rubber Co.
|
New York Times Co. (The) | |
Dade Behring Holdings Inc.
|
PerkinElmer Inc. | |
DENTSPLY International Inc.
|
Plexus Corp. | |
Discovery Holding Co.
|
Plum Creek Timber Co. Inc. | |
Dollar Thrifty Automotive Group Inc.
|
PolyOne Corp. | |
Donaldson Co. Inc.
|
Respironics Inc. | |
Dow Jones and Co. Inc.
|
Scotts Miracle Gro Company (The) | |
Equifax Inc.,
|
Steelcase Inc. | |
Fleetwood Enterprises Inc.
|
Tektronix Inc. | |
Forest Laboratories Inc.
|
Tele Tech Holdings Inc. | |
GATX Corp.
|
Terra Industries Inc. | |
Genzyme Corp.
|
Thomas & Betts Corp. | |
Gilead Sceiences Inc.
|
Tiffany & Co. | |
Global Crossing Ltd.
|
Toro Co. (The) | |
Grace (WR) & Co.
|
Trinity Industries Inc. | |
H.B. Fuller Co.
|
Tupperware Brands Corp. | |
Harman International Industries Inc.
|
Valmont Industries Inc. | |
Harsco Corp.
|
Viad Corp. | |
Hasbro Inc.
|
Watson Pharmaceuticals Inc. | |
Hayes Lemmerz International Inc.
|
Wendys International Inc. | |
Hercules Inc.
|
Winnebago Industries Inc. |
D-1
AMETEK Inc.
|
McDermott International Inc. | |
Barnes Group Inc.
|
Myers Industries Inc. | |
Brady Corp
|
National Presto | |
Carlisle Companies Inc.
|
Oakley Inc. | |
Chemed Corp
|
Parker-Hannifin Corp | |
Crane Co.
|
Park Ohio Holdings Corp | |
Danaher Corp
|
Pentair Inc. | |
ESCO Technologies Inc.
|
SPX Corp | |
Fortune Brands Inc.
|
Standex International Corp | |
GATX Corp
|
Teleflex Inc. | |
GenCorp Inc.
|
Textron Inc. | |
General Electric
|
Tyco International Ltd. | |
Griffon Corp.
|
United Technologies Corp | |
Honeywell International Inc.
|
Valmont Industries Inc. | |
ITT-Corp
|
Viad Corp | |
Kadant Inc.
|
Walter Industries | |
Kaman Corp
|
E-1
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. KEEP THIS PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION ONLY TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date To withhold authority to vote for any individual nominee(s), mark For All Except and write the number(s) of the nominee(s) on the line below. 0 0 0 0 0 0 00000565131 R2.09.05.010 For Withhold For All All All Except The Board of Directors recommends that you vote FOR the following: 1. Election of Directors Nominees 01 Alan R. Buckwalter 02 Victor L. Lund 03 John W. Mecom, Jr. SERVICE CORPORATION INTERNATIONAL ATTN: INVESTOR RELATIONS 1929 ALLEN PARKWAY HOUSTON, TX 77019 VOTE BY INTERNET www.proxyvote.com Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. Electronic Delivery of Future PROXY MATERIALS If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years. VOTE BY PHONE 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. The Board of Directors recommends you vote FOR the following proposal(s): For Against Abstain 2 Approval of the selection of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for fiscal 2010. NOTE: Such other business as may properly come before the meeting or any adjournment thereof. Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name, by authorized officer. 00000565132 R2.09.05.010 |
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice & Proxy Statement, Form 10-K is/are available at www.proxyvote.com . SERVICE CORPORATION INTERNATIONAL PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS For The Annual Meeting of Shareholders May 12, 2010 The undersigned hereby appoints Thomas L. Ryan, Gregory T. Sangalis and Eric D. Tanzberger, and each or any of them as attorneys, agents and proxies of the undersigned with full power of substitution, for and in the name, place and stead of the undersigned, to attend the annual meeting of shareholders of Service Corporation International (the Company) to be held in the York Distributors Association Auditorium, American Funeral Service Training Center, 415 Barren Springs Drive, Houston, Texas 77090 on Wednesday, May 12, 2010, at 9:00 a.m., Houston time, and any adjournment(s) thereof, and to vote thereat the number of shares of Common Stock of the Company which the undersigned would be entitled to vote if personally present as indicated on the reverse side hereof and, in their discretion, upon any other business which may properly come before said meeting. This proxy, when properly executed, will be voted in accordance with your indicated directions. If no direction is made, this proxy will be voted FOR the election of directors and FOR approval of the selection of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm. Continued and to be signed on reverse side |